CellaVision Balance Sheet Health
Financial Health criteria checks 5/6
CellaVision has a total shareholder equity of SEK767.9M and total debt of SEK35.4M, which brings its debt-to-equity ratio to 4.6%. Its total assets and total liabilities are SEK983.8M and SEK216.0M respectively. CellaVision's EBIT is SEK188.9M making its interest coverage ratio -577.6. It has cash and short-term investments of SEK137.7M.
Key information
4.6%
Debt to equity ratio
SEK 35.39m
Debt
| Interest coverage ratio | -577.6x |
| Cash | SEK 137.66m |
| Equity | SEK 767.86m |
| Total liabilities | SEK 215.98m |
| Total assets | SEK 983.84m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: C26's short term assets (SEK393.5M) exceed its short term liabilities (SEK129.4M).
Long Term Liabilities: C26's short term assets (SEK393.5M) exceed its long term liabilities (SEK86.6M).
Debt to Equity History and Analysis
Debt Level: C26 has more cash than its total debt.
Reducing Debt: C26's debt to equity ratio has increased from 0% to 4.6% over the past 5 years.
Debt Coverage: C26's debt is well covered by operating cash flow (646.8%).
Interest Coverage: C26 earns more interest than it pays, so coverage of interest payments is not a concern.